biospecimen_aliquot__bcr_aliquot_barcode	tcga-e9-a226-01a-21d-a159-09
biospecimen_aliquot__bcr_aliquot_uuid	866e5e9b-4e6c-49e2-9ea6-560f9bd99c2b
biospecimen_aliquot__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
biospecimen_aliquot__bcr_sample_barcode	tcga-e9-a226-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099054612
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.09
biospecimen_aliquot__date_of_shipment	2011-05-17
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	3
biospecimen_aliquot__plate_id	a159
biospecimen_aliquot__plate_row	e
biospecimen_aliquot__quantity	3.60
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.79
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e9-a226-01a-21d
biospecimen_analyte__bcr_analyte_uuid	5623bb78-dd46-4f95-9936-0283e4120135
biospecimen_analyte__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
biospecimen_analyte__bcr_sample_barcode	tcga-e9-a226-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e9-a226
biospecimen_diagnostic_slides__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e9-a226-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	14f1f4c7-4e6e-4574-af20-60d2ab511b2a
biospecimen_normal_control__bcr_patient_barcode	tcga-e9-a226
biospecimen_normal_control__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
biospecimen_portion__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
biospecimen_portion__bcr_portion_barcode	tcga-e9-a226-01a-21
biospecimen_portion__bcr_portion_uuid	1d92047b-cf43-4360-8549-2c5ae613bcb2
biospecimen_portion__bcr_sample_barcode	tcga-e9-a226-01a
biospecimen_portion__date_of_creation	2011-04-11
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	21
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e9-a226-01a-21d
biospecimen_protocol__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
biospecimen_protocol__bcr_sample_barcode	tcga-e9-a226-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
biospecimen_sample__bcr_sample_barcode	tcga-e9-a226-01a
biospecimen_sample__bcr_sample_uuid	c1adf54e-8248-4b44-a9a1-e883fcc4f702
biospecimen_sample__days_to_collection	48
biospecimen_sample__initial_weight	510
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-e9-a226.7c8f01dc-9cd9-4d61-9032-bc9f28a687ee.pdf
biospecimen_sample__pathology_report_uuid	7c8f01dc-9cd9-4d61-9032-bc9f28a687ee
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e9-a226-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	67837600-8189-44bd-af2f-1cb30522bc65
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17k
biospecimen_shipment_portion__portion_number	11
biospecimen_shipment_portion__portion_sequence	1
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e9-a226-01a-11-a17k-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
biospecimen_slide__bcr_sample_barcode	tcga-e9-a226-01a
biospecimen_slide__bcr_slide_barcode	tcga-e9-a226-01a-02-tsb
biospecimen_slide__bcr_slide_uuid	794150b5-08d4-4a83-82e4-6c8a812bd236
biospecimen_slide__image_file_name	tcga-e9-a226-01a-02-tsb.794150b5-08d4-4a83-82e4-6c8a812bd236.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	0
biospecimen_slide__percent_tumor_cells	100
biospecimen_slide__percent_tumor_nuclei	65
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e9-a226
biospecimen_tumor_sample__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
clinical_drug__bcr_drug_barcode	tcga-e9-a226-d55887
clinical_drug__bcr_drug_uuid	2c88b47f-36aa-43af-95bb-33939622235f
clinical_drug__bcr_patient_barcode	tcga-e9-a226
clinical_drug__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
clinical_drug__form_completion_date	2014-1-17
clinical_drug__pharmaceutical_therapy_drug_name	pamidronate
clinical_drug__pharmaceutical_therapy_type	ancillary
clinical_drug__pharmaceutical_tx_ended_days_to	937
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	790
clinical_drug__treatment_best_response	partial response
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-e9-a226-f29953
clinical_follow_up__bcr_followup_uuid	13947f51-baed-4f88-969d-895b7bffb55d
clinical_follow_up__bcr_patient_barcode	tcga-e9-a226
clinical_follow_up__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2013-1-17
clinical_follow_up__last_contact_days_to	628
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	45
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n2
clinical_patient__ajcc_pathologic_tumor_stage	stage iiia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left lower inner quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-e9-a226
clinical_patient__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
clinical_patient__birth_days_to	-16511
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-8-3
clinical_patient__gender	female
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2011
clinical_patient__last_contact_days_to	16
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	10
clinical_patient__lymph_nodes_examined_he_count	6
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	cytology (e.g. peritoneal or pleural fluid)
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a226
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	e9
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e9-a226
clinical_radiation__bcr_patient_uuid	dd67408e-46ba-4573-9415-d4814e9f84de
clinical_radiation__bcr_radiation_barcode	tcga-e9-a226-r29958
clinical_radiation__bcr_radiation_uuid	0516ac70-e0bc-4a79-b7e7-95cc9ed41de0
clinical_radiation__form_completion_date	2012-3-30
clinical_radiation__radiation_adjuvant_fractions_total	20
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	117
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	regional site
clinical_radiation__radiation_therapy_started_days_to	94
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	4000
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E9-A226-01A-21D-A159-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E9-A226-01A-21D-A159-09.bed.meta
manually_curated__id	tcga-e9-a226-01a-21d-a159-09
manually_curated__md5sum	7702676fd2b6c4ae568da245f311fa84
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	866e5e9b-4e6c-49e2-9ea6-560f9bd99c2b
manually_curated__tumor_tag	brca
